UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000032785
Receipt number R000037398
Scientific Title Evaluation of computed tomography lymphography as a diagnostic modality for lymph node metastasis in esophageal cancer
Date of disclosure of the study information 2018/07/01
Last modified on 2023/06/10 18:33:00

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Evaluation of computed tomography lymphography as a diagnostic modality for lymph node metastasis in esophageal cancer

Acronym

Lymph node metastatic diagnosis in esophageal cancer using CT lymphography

Scientific Title

Evaluation of computed tomography lymphography as a diagnostic modality for lymph node metastasis in esophageal cancer

Scientific Title:Acronym

Lymph node metastatic diagnosis in esophageal cancer using CT lymphography

Region

Japan


Condition

Condition

Superficial esophageal cancer

Classification by specialty

Medicine in general Gastroenterology Surgery in general
Gastrointestinal surgery Radiology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To evaluate diagnostic accuracy of lymph node metastasis using CT lymphography in superficial esophageal cancer

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

diagnostic accuracy of lymph node metastasis using CT lymphography in superficial esophageal cancer

Key secondary outcomes

1) sensitivity and specificity of lymph node diagnosis
2) Local lymph node recurrence within 3 years after surgery


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

100 years-old >=

Gender

Male and Female

Key inclusion criteria

1. superficial esophageal cancer from cervical to esopago-gastric junction (Sievert typeII) including suquamous cell carcinoma or adenocarcinoma
2. depth of tumor: submucosal layer in the endoscopic findings

Key exclusion criteria

1. kidney injury (eGFR<40ml/min)
2. dysfunction of the liver with esophageal varices
3. branchial asthma
4. pregnancy
5. allergy to iodine

Target sample size

80


Research contact person

Name of lead principal investigator

1st name Akira
Middle name
Last name Tangoku

Organization

Institute of Biomedical Sciences
Tokushima University Graduate School

Division name

Department of Thoracic, Endocrine Surgery and Oncology

Zip code

7708503

Address

3-18-15 Kuramoto-cho, Tokushima 770-8503, Japan

TEL

0886337143

Email

tangoku@tokushima-u.ac.jp


Public contact

Name of contact person

1st name Takahiro
Middle name
Last name Yoshida

Organization

Institute of Biomedical Sciences Tokushima University Graduate School

Division name

Department of Thoracic, Endocrine Surgery and Oncology

Zip code

7708503

Address

3-18-15 Kuramoto-cho, Tokushima 770-8503, Japan

TEL

0886337143

Homepage URL

http://www.tksbizan.com/medical/kyoushitsu.html

Email

tyoshida1@tokushima-u.ac.jp


Sponsor or person

Institute

Department of Thoracic, Endocrine Surgery and Oncology
Institute of Biomedical Sciences
Tokushima University Graduate School

Institute

Department

Personal name



Funding Source

Organization

Department of Thoracic, Endocrine Surgery and Oncology
Institute of Biomedical Sciences
Tokushima University Graduate School

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Institute of Biomedical Sciences, Tokushima University Graduate School

Address

3-18-15, Kuramoto-cho, Tokushima

Tel

088-633-7143

Email

tyoshida1@tokushima-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2018 Year 07 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2018 Year 08 Month 30 Day

Date of IRB

2020 Year 09 Month 08 Day

Anticipated trial start date

2018 Year 09 Month 01 Day

Last follow-up date

2023 Year 06 Month 09 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded

2023 Year 06 Month 09 Day


Other

Other related information

Prognostic power in CT lymphography compared with conventional CT is investigated in this study. Positive predictive value and negative predictive value are calculated.


Management information

Registered date

2018 Year 05 Month 30 Day

Last modified on

2023 Year 06 Month 10 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000037398


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name